<DOC>
	<DOCNO>NCT01198275</DOCNO>
	<brief_summary>The purpose study determine effect n-3 PUFAs addition amiodarone renin-angiotensin-aldosterone system ( RAAS ) inhibitor maintenance sinus rhythm electrical conversion patient persistent Atrial fibrillation ( AF ) .</brief_summary>
	<brief_title>n-3 Polyunsaturated Fatty Acids ( PUFAs ) Prevention Atrial Fibrillation</brief_title>
	<detailed_description>Atrial fibrillation ( AF ) common sustain arrhythmia represent increase burden healthcare system . Treatment AF remain controversial . In patient antiarrhythmic therapy , one-year relapse rate AF cardioversion range 44 % 77 % one year amiodarone appear effective maintain sinus rhythm.Over last year , grow amount evidence support protective effect n-3 PUFAs prevent ventricular arrhythmia reduce risk sudden cardiac death . Furthermore , last year , interest possible beneficial role AF prevention increasing.We hypothesize administration n-3 PUFAs could reduce AF recurrence rate amiodarone plus RAAS inhibitor patient persistent AF . Therefore present study aim evaluate role n-3 PUFAs prophylaxis AF recurrences DCCV addition amiodarone RAS blocker therapy patient persistent AF .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Amiodarone</mesh_term>
	<criteria>persistent Atrial Fibrillation ( AF ) last &gt; one month history least one AF relapse previous electrical Pharmacological cardioversion leave atrium size &gt; 6 cm severe valvulopathy myocardial infarction previous 6 month unstable angina NYHA heart failure class IV hemodynamic instability cardiac surgery previous 3 month significant pulmonary thyroid hepatic disease contraindication treatment amiodarone RASS inhibitor chronic renal dysfunction QT &gt; 480 msec absence bundlebranch block bradycardia &lt; 50 b/min diagnosis paroxysmal AF hyperkalemia pregnancy disease medical treatment , opinion investigator , could interfere study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>PUFA atrial fibrillation</keyword>
</DOC>